Synthesis of a 2-Aminoimidazole Library for
Antibiofilm Screening Utilizing the Sonogashira
Reaction
Justin J. Richards and Christian Melander*
FIGURE 1. Previously reported 2-AI biofilm modulators.
Department of Chemistry, North Carolina State UniVersity,
Our group has been actively investigating the effects that
simple sponge-derived marine alkaloids and their derivatives
have upon biofilm development and maintenance in medically
relevant bacteria.8,9 The 2-aminoimidazole (2-AI) motif, preva-
lent in all members of the oroidin family of natural products,10
serves as the inspiration in the design and evaluation of these
analogues (Figure 1). In order to generate additional diversity
around the 2-AI scaffold, new avenues for the synthesis of large
numbers of compounds are needed.
Raleigh, North Carolina 27695
ReceiVed March 18, 2008
Despite this need for 2-AI based motifs that would provide
a suitable handle for rapid analogue construction and evaluation
as antibiofilm agents, there remains a lack of known methods
for their quick generation. It was therefore a goal to take
advantage of palladium-catalyzed cross-coupling reactions in
aiding the synthesis of these aforementioned chemical libraries.
Among the known palladium-catalyzed carbon-carbon bond-
forming reactions, the Sonogashira reaction11 is known to
proceed under fairly mild conditions12,13 and would give the
option of simultaneously providing entrance into further ad-
vanced analogues through exploitation of the triple bond into
alkene and alkane based derivatives. It was also envisioned that
by performing the couplings at various positions along the core
phenyl ring, the position effect of the alkynyl appendage on
activity could be evaluated. Herein we report the synthesis of a
21-member library that employs a high-yielding Sonogashira
reaction on three aryl iodide protected 2-aminoimidazole
scaffolds to generate novel small molecules applicable for
screening as antibiofilm agents.
Access to the desired aryl halide intermediates for the
Sonogashira coupling was executed through the commercially
available ortho, meta, and para substituted iodobenzoic acid
derivatives 3-5 (Scheme 1). Each was first transformed into
its acid chloride before being sequentially reacted with diaz-
omethane and quenched with concentrated HBr. This afforded
the requisite R-bromo ketones 6-8 in excellent yields. Instal-
lation of the 2-aminoimidazole subunit was achieved through
condensation with Boc-guanidine14 in the presence of NaI.
Attempts at performing the Sonogashira reaction with interme-
The divergent synthesis of a 21-member library composed
of 2-aminoimidazole compounds for evaluation as novel
antibiofilm molecules is presented. The Sonogashira reaction
was employed with three regioisomeric aryl iodides and 11
different alkynes to generate variously substituted diverse
ring systems. Good to excellent yields (80-97%) for the
reaction were obtained, and the products provide adequate
handles for further manipulation into more advanced
analogues.
Bacterial biofilms have recently been estimated by the NIH
as being responsible for upward of 80% of microbial infections
in the human body.1 They also possess increased resistance to
basic host immune responses, antiseptics, and antibiotics, often
representing a significant challenge to overcome as evident by
the increased morbidity and mortality rates of numerous biofilm-
mediated diseases.2,3 Biofilms are described as highly organized
structures composed of a complex matrix of bacteria and
biomolecules.4 They form when planktonic bacteria irreversibly
bind to a surface suitable for growth and initiate the formation
of a microcolony. On a global scale, biofilm-related costs incur
billions of dollars to the agricultural, engineering, and medical
sectors of the economy. Recently, there has been an intense
effort to investigate small molecules that either retard biofilm
development or, more importantly, disperse existing biofilms
in hopes of providing a therapeutic tool in combating the serious
problems they underpin.5–7
(6) Hu, J. F.; Garo, E.; Goering, M. G.; Pasmore, M.; Yoo, H. D.; Esser, T.;
Sestrich, J.; Cremin, P. A.; Hough, G. W.; Perrone, P.; Lee, Y. S. L.; Le, N. T.;
O’Neil-Johnson, M.; Costerton, J. W.; Eldridge, G. R. J. Nat. Prod. 2006, 69,
118–120.
(7) Junker, L. M.; Clardy, J. Antimicrob. Agents Chemother. 2007, 51, 3582–
3590.
(8) Huigens, R. W.; Richards, J. J.; Parise, G.; Ballard, T. E.; Zeng, W.;
Deora, R.; Melander, C. J. Am. Chem. Soc. 2007, 129, 6966–6967.
(9) Richards, J. J.; Huigens, R. W.; Ballard, T. E.; Basso, A.; Cavanagh, J.;
Melander, C. Chem. Commun. 2008, 1698–1700.
(1) Davies, D. Nat. ReV. Drug DiscoVery 2003, 2, 114–122.
(2) Costerton, J. W.; Stewart, P. S.; Greenberg, E. P. Science 1999, 284,
1318–1322.
(10) Hoffmann, H.; Lindel, T. Synthesis 2003, 1753–1783.
(11) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467–
4470.
61.(3) Rasmussen, T. B.; Givskov, M. Int. J. Med. Microbiol. 2006, 296, 149–
(4) Musk, D. J.; Hergenrother, P. J. Curr. Med. Chem. 2006, 13, 2163–2177.
(5) Geske, G. D.; Wezeman, R. J.; Siegel, A. P.; Blackwell, H. E. J. Am.
Chem. Soc. 2005, 127, 12762–12763.
(12) Chinchilla, R.; Najera, C. Chem. ReV. 2007, 107, 874–922.
(13) Schnurch, M.; Flasik, R.; Khan, A. F.; Spina, M.; Mihovilovic, M. D.;
Stanetty, P. Eur. J. Org. Chem. 2006, 3283–3307.
10.1021/jo800618q CCC: $40.75
Published on Web 06/04/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 5191–5193 5191